Article · 2013
Conference abstractPublished 7 Dec 2016
Restaging rectal cancer after neoadjuvant chemo radiotherapy: For a down-staging classification
University of Modena, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Today neoadjuvant chemoradiation for T2 and T3 rectal cancers is widely adopted. Surgery is usually performed after 5-6 weeks from the beginning of the therapy and it is our policy to perform a restaging of the tumor at that moment, in order to obtain its down-staging, to discover possible complications related to the treatment, to confirm or adjust a surgical strategy, to evaluate risks for possible recurrence, and to schedule an adequate follow-up. For this, we have implemented a classification of the tumor down-staging, mainly based on radiological imaging results, contrast-enhanced computed tomography and magnetic resonance, and inspired to the current TNM scheme. Neoplastic regression inside rectal walls and mesorectum have been considered of prominent significance, and, therefore, discriminating in surgery. Besides, these aspects correlate well with the biological attitude of rectal cancer to regress following a centripetal way, starting from the most peripheral and recent zones of infiltration toward the central core of the tumor, where the tissue involvement is more marked. Interestingly, in our experience of 38 cases observed in the years 2012-2015, the down-staging score appears inversely correlated with the histological grading of the tumor, but directly with the DowrakâÂ?Â?s tumour regression. Certainly our classification needs to be confirmed by further clinical studies, which will have to consider also the different molecular characteristics of rectal cancer.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 27 Feb 2017
Effects of Adjuvant Oxaliplatin on Anal Function in Locally Advanced Rectal Cancer Treated with Preoperative Chemo-Radiotherapy and Low Anterior Resection
Conference abstract · 27 Aug 2018
Delay to systemic chemotherapy, survival and recurrence in patients of rectal cancer treated with neoadjuvant chemo-radiotherapy and surgery
Short communication · 29 Jul 2022
Mechanical versus laparoscopic medical procedure for rectal malignant growth after neoadjuvant chemo radiotherapy: An inclination score matching examination.
Research article · 29 Nov 2016
Is there a Role of Lateral Pelvic Lymph Node Dissection in the Current Era of Neoadjuvant Chemoradiotherapy for Rectal Cancer?
More from this journal
The newest in Journal of Gastrointestinal & Digestive System.
Research article · 1 Jan 2026
Prospective Observational Study for the Evaluation of Efficacy and Safety Profile of Probiotics Food Supplement in Children with Acute Diarrhea
Case report · 11 Nov 2025
Bitter Guard: A Gut Wrenching Surprise
Research article · 18 Jun 2025
Ursodeoxycholic Acid Treatment of LPAC Presenting as Post Cholecystectomy Pain: Rationale and Design of a Randomised Trial
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Antonio Manenti”
- BylineArticles whose byline prints “Luca Roncati”
- BylineArticles whose byline prints “Massimiliano Salati”
- BylineArticles whose byline prints “Emilio Simonini”
- BylineArticles whose byline prints “Maurizio Zizzo”
- BylineArticles whose byline prints “Alberto Farinetti”
